The peptides industry frequently operates within ambiguous regulatory boundaries. While peptides may be permissible with a prescription in certain regions, numerous payment processors have opted to restrict merchant account services for SARMS and peptides, consequently removing supplement credit card processing accounts from their offerings. A notable hurdle faced by merchants in this sector revolves around the acquisition of a dependable merchant account.
High Risk Merchant Account & Payment Processing Solutions
Supplements encompass a wide array of products used for health, weight management, and sports purposes, including vitamins, minerals, herbals, and botanicals. While manufacturers must adhere to federal safety regulations, the lack of certification for health claims often categorizes these products as higher-risk by banks and payment processors. This classification complicates the process of obtaining a merchant account, particularly for SARMS and peptides, which are known for their muscle-building properties and face difficulties due to perceived risks.
SARMS, or Selective Androgen Receptor Modulators, are synthetic drugs similar to steroids, targeting muscles without affecting other body parts. Peptides, on the other hand, are smaller versions of proteins with specific health benefits, such as anti-aging and muscle-building properties. Despite being legal for sale in some regions, SARMS and peptides pose challenges in securing supplement merchant accounts due to their unapproved status for human consumption. In response to dwindling credit card processing options, merchants have turned to alternative high-risk payment methods like electronic checks, supported by smaller financial institutions and adhering to local regulations. This shift offers a viable solution for processing transactions in the SARMS and peptides industries, despite their high-risk nature.